ERBB2 and neoplasm: The results of this study show that SUVmax (Supplementary Table S2) was significantly higher in HER2-positive primary breast tumours (8.8 ± 2.7) compared to HER2-negative tumours (3.5 ± 1.4) (p < 0.0001, Mann–Whitney test).